EpilepsyGTx is based in London, United Kingdom. It has raised $43M in total funding. Latest round: Series A.
EpilepsyGTx funding overview
EpilepsyGTx is based in London, United Kingdom. EpilepsyGTx has raised $43M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in December 2025. The round record for EpilepsyGTx runs through 2025; nothing later has been disclosed. Investors on record include XGEN Venture, British Business Bank, UCL Technology Fund 2, Health Technology Holding, Undisclosed global biopharmaceutical company. 5 distinct backers are named across the disclosed rounds.
EpilepsyGTx at a glance
Total raised
$43M
Latest round
Series A
Latest round date
December 2025
Headquarters
London, United Kingdom
Notable investors
XGEN Venture, British Business Bank, UCL Technology Fund 2, Health Technology Holding, Undisclosed global biopharmaceutical company
Frequently asked about EpilepsyGTx funding
How much has EpilepsyGTx raised?
EpilepsyGTx has raised $43M in total disclosed funding across the rounds on record.
Who has invested in EpilepsyGTx?
XGEN Venture, British Business Bank, UCL Technology Fund 2, Health Technology Holding, Undisclosed global biopharmaceutical company are named among the investors backing EpilepsyGTx.
What was the latest EpilepsyGTx funding round?
The most recent disclosed round is a Series A, announced in December 2025.
Where is EpilepsyGTx based?
EpilepsyGTx is based in London, United Kingdom.
When did EpilepsyGTx last raise?
The last disclosed EpilepsyGTx round closed in December 2025 at Series A.
Round data for EpilepsyGTx is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in London and backer lists below.
